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We appreciate the interest of Drs Wilcox and McNamara in our work. We do not think that the enhanced central chemoreflex sensitivity in our patients was secondary to occult central or obstructive apnea for the following reasons. First, 4 of our heart failure patients underwent sleep studies, which ruled out sleepdisordered breathing. Ventilatory and autonomic responses to hypercapnia were markedly increased in these subjects. Second, in all subjects, we evaluated respiratory patterns over 2 hours of supine rest. None of the patients had evidence of apneas or hypopneas. Third, there was no difference in baseline CO 2 between heart failure patients and controls in our study, whereas Wilcox et al 1 demonstrated that patients with central sleep apnea had low CO 2 during wakefulness. Fourth, in contrast to findings in patients with heart failure, patients with obstructive sleep apnea who are free of any other diseases have enhanced peripheral but not central chemoreflex sensitivity compared with closely matched controls. 2 Wilcox and McNamara make important points regarding the complex interaction between heart failure, chemoreflex function, and sleep-disordered breathing. Chemoreflex function in heart failure may be influenced by several factors, including species, 3, 4 the origin of the heart failure, 3, 4 and the presence of coexisting disease states. Furthermore, it has also been proposed that enhanced sensitivity to CO 2 may contribute to the development of central sleep apnea in patients with heart failure. 
